LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Diagnostic Errors Lead to Inappropriate Antimicrobial Use

By LabMedica International staff writers
Posted on 01 Jun 2015
Image: An antibiogram showing a culture plate with different antibiotic discs and bacterial sensitivity (Photo courtesy of World Health Organization).
Image: An antibiogram showing a culture plate with different antibiotic discs and bacterial sensitivity (Photo courtesy of World Health Organization).
Misdiagnoses can lead to increased risk of incorrect antibiotic use, threatening patient outcomes and antimicrobial efficacy, while increasing healthcare costs.

All antimicrobial use establishes selective pressure that contributes to the relentless emergence of resistance in a broad array of pathogens and antimicrobial stewardship programs have been introduced to improve antimicrobial therapy, but in most cases improvements are modest.

Infectious disease specialists at the Minneapolis Veterans Affairs Health Care System, (Minnesota, MN, USA) and their university colleagues, conducted a retrospective cohort study at their Medical Center (MVAMC), evaluating 500 inpatient cases to examine provider diagnoses, categorized as either correct, indeterminate, incorrect, or a sign or symptom consistent with an infectious disease rather than a specific syndrome or disease, and to determine whether the antimicrobial course prescribed was appropriate.

The scientists found that 95% of patients with an incorrect or indeterminate diagnosis, or with a symptom identified but no diagnoses made, were given inappropriate antibiotics. By comparison, only 38% of patients who received a correct diagnosis were incorrectly given antibiotics. The inappropriate use of antibiotics contributes to antibiotic resistance, clinical failure, adverse drug events, and excessive costs. Additionally, they found that overall, only 58% of patients received a correct diagnosis, indicating that diagnostic errors were more prevalent in their study than in previous studies unrelated to antimicrobial use. The most common incorrect diagnoses identified by the specialists were pneumonia, cystitis, urinary tract infections, kidney infections and urosepsis.

The authors concluded that the impact of diagnostic accuracy on the appropriateness of antimicrobial therapy and they provide a detailed analysis of types and predictors of diagnostic errors and their relationship to types of inappropriate antimicrobial use. These findings suggest that more studies are needed to elucidate mechanisms of diagnostic errors related to antimicrobial prescribing. They also suggest that antimicrobial stewardship programs could increase their impact if they were designed to help providers make accurate initial diagnoses and to help providers know when antimicrobial therapy can be safely withheld.

Gregory A. Filice, MD, lead author of the study, said, “Diagnostic accuracy is integral to the safe use of antibiotics. In order to improve the use of antibiotics in healthcare, we must consider this challenge and look for tools and strategies that help clinicians decrease unnecessary and potentially harmful antibiotic use.” The study was published on May 18, 2015, in the journal Infection Control & Hospital Epidemiology

Related Links:
.
Minneapolis Veterans Affairs Health Care System 


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Sample Transportation System
Tempus1800 Necto

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more